Abstract:Introduction In Pulmonary arterial hypertension (PAH), the right atrium plays a critical role, and its size, determined by echocardiography, is crucial for risk stratification. Despite this, current guidelines still prioritize right atrial area (RAA) over the right atrial volume index (RAVI). This approach is contrary to the recommendations of international echocardiography societies since 2016, which advocate for the use of RAVI for a more accurate assessment. Purpose Identify the RAVI value corresponding to the RAA, in PAH risk stratification used in the 2022 ESC guidelines. Methods We conducted a retrospective analysis of all consecutive patients of a single-center, since 2002. Patient's echocardiograms were revised for simultaneous assessment of RAA and right atrial volume index (RAVI). Over an average follow-up of 6.7 years (SD 5.9), we recorded a cohort of 82 patients diagnosed with PAH. From this group, we excluded 27 patients with congenital etiologies, 14 due to the insufficient quality of echocardiographic data, and one patient identified as an extreme statistical outlier. A Pearson's correlation analysis was used to access the correlation between RAA and RAVI for PAH diagnosis. Results A total of 40 patients were included with a mean age at diagnosis of 48.85 years (SD 17.82), predominantly female (77.5 %). The most prevalent etiologies were idiopathic (32.5%) and connective tissue disease-associated PAH (27.5%). Clinical presentations included right heart failure signs in 30% of patients, rapid symptom progression in 12.5%, syncope history in 15% and 77.5% in WHO-FC III-IV. Average 6-MWD and NT-proBNP levels were 392,1 m (SD 120,2) and 1636,18 ng/L (SD 2576,14), respectively. Average hemodynamics parameters were right atrial pressure 7,39 mmHg (SD 4,940); cardiac index 2,28 L/min/m2 (SD 2,06); stroke volume index 3,38 mL/m2 (SD 3,92) and mixed venous oxygen saturation 65,68% (SD 10,86). Average echocardiographic parameters were RAA 20,14 cm2 (SD 4,80); TAPSE/sPAP 0,34 mm/mmHg (SD 0,18) and RAVI 37,78 mL/m2 (SD 13,67), with 10% of pericardial effusion. Statistical analysis revealed a strong and significant correlation between RAA and RAVI (r=0.82, 95% CI: 0.69-0.90, p<0.001). The derived linear relationship is expressed as "y=2.8*X -18". Therefore, an RAA value of 18 cm2 translates to a RAVI of 32 mL/m2, while an RAA of 26 cm2 corresponds to a RAVI of 55 mL/m2. Conclusion Our study supports a revision in HAP risk assessment guidelines, suggesting a shift to a more comprehensive approach using right atrial volume index (RAVI) measurements. We propose categorizing risk as low for RAVI 55 mL/m2. This recommendation aligns with the standards of international societies and is grounded in best clinical practices, considering that indexing measurements of the right atrium to body size potentially offers greater accuracy than absolute values.

Association between right heart size and right ventricular output reserve in patients with pulmonary arterial hypertension

Right Heart Size and Right Ventricular Reserve in Pulmonary Hypertension: Impact on Management and Prognosis

Elevated Right Atrial Pressure Associated with Alteration of Left Ventricular Contractility and Ventricular-Arterial Coupling in Pulmonary Artery Hypertension

Evaluation of Right Ventricular Regional Volume and Systolic Function in Patients with Pulmonary Arterial Hypertension Using Three-Dimensional Echocardiography

Impact of Severe Pulmonary Arterial Hypertension on the Left Heart and Prognostic Implications

Poor cardiac output reserve in pulmonary arterial hypertension is associated with right ventricular stiffness and impaired interventricular dependence

P4537Prolonged Right Ventricular Systolic to Diastolic Duration Ratio Predicts Mortality in Idiopathic Pulmonary Arterial Hypertension

Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension

Right Heart End-Systolic Remodeling Index Strongly Predicts Outcomes in Pulmonary Arterial Hypertension: Comparison With Validated Models

Association between right atrial area measured by echocardiography and prognosis among pulmonary arterial hypertension: a systematic review and meta-analysis

Identifying consistent echocardiographic thresholds for risk stratification in pulmonary arterial hypertension

Cardiac Remodelling Amongst Adults with Various Aetiologies of Pulmonary Arterial Hypertension Including Eisenmenger Syndrome—implications on Survival and the Role of Right Ventricular Transverse Strain

Right atrial and ventricular strain detects subclinical changes in right ventricular function in precapillary pulmonary hypertension

Optimal combination of right ventricular functional parameters using echocardiography in pulmonary arterial hypertension

Three-dimensional Echocardiography to Evaluate Right Atrial Volume and Phasic Function in Pulmonary Hypertension.

Physiological mechanisms behind respiratory variations in right atrial pressure in pulmonary hypertension

Enhanced pulmonary vasodilator reserve and abnormal right ventricular: pulmonary artery coupling in heart failure with preserved ejection fraction

Right ventricular outflow tract diameter change with exercise: a prospective exercise echocardiography and invasive CPET study

Echocardiographic insights redefining risk in pulmonary arterial hypertension: a focus on right atrial volume index for enhanced stratification

Right Ventricular Systolic to Diastolic Duration Ratio: A Novel Predictor of Outcome in Adult Idiopathic Pulmonary Arterial Hypertension.

Right-Ventricle Heart Failure in PAH vs. HFrEF with Secondary PH: Hemodynamic, Ergospirometric, and Organ Function Correlations